Loading…
Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor
Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 1998-05, Vol.95 (11), p.6061-6066 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243 |
---|---|
cites | cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243 |
container_end_page | 6066 |
container_issue | 11 |
container_start_page | 6061 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 95 |
creator | Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) Farruggella, T.J Symes, A Karow, M.L Yancopoulos, G.D Stahl, N |
description | Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals |
doi_str_mv | 10.1073/pnas.95.11.6061 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16355727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>45331</jstor_id><sourcerecordid>45331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</originalsourceid><addsrcrecordid>eNqFkcFrFDEUxgdRaq2eBUEZPOhptu9lJpMJeJFSrVDoofYcspk3u1lmkzHJVvvfm2GXpXrQUxK-3_fxXr6ieI2wQBD1-eR0XEi-QFy00OKT4hRBYtU2Ep4WpwBMVF3DmufFixg3ACB5ByfFiWzzFcVpoS_dWjtj3aocaUrWlYHi5F2kcvlQToHuyaVZvb1ilfEuaevm57T2cVrrpDPISusSBW2S9a78adO6vFnmHJMDfXhZPBv0GOnV4Twr7r5cfr-4qq5vvn67-HxdGd5AqrDDBpC4bqkzIEUtBXEAanu27JeG9WKQvcnLGdELol52QgN1PQ68R2JNfVZ82udOu-WWepPnDnpUU7BbHR6U11b9qTi7Vit_r5jgHc_2Dwd78D92FJPa2mhoHLUjv4tKyE4CCPFfENuac8Fm8P1f4Mbvgst_oBhg3eUwzND5HjLBxxhoOA6MoOaG1dywklwhqrnh7Hj7eM8jf6g06x8P-mw8qscANezGMdGvlMl3_yQz8GYPbGIu8kg0vK4fzTFor_Qq2KjublFKAbJm2NW_Ae_1zYY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201380771</pqid></control><display><type>article</type><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>PubMed Central</source><creator>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</creator><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</creatorcontrib><description>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.95.11.6061</identifier><identifier>PMID: 9600917</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>ADN RECOMBINADO ; ADN RECOMBINE ; Animals ; Antibodies ; BINDING ; Biochemistry ; Biological Sciences ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; COS Cells ; Cytokines ; DNA-Binding Proteins - metabolism ; ESTERASAS ; ESTERASE ; ESTERASES ; EXPRESION GENICA ; EXPRESSION DES GENES ; FACTEUR DE TRANSCRIPTION ; FACTORES DE TRANSCRIPCION ; FOSFORILACION ; GENE ; GENE EXPRESSION ; Gene induction ; GENES ; GENETIC REGULATION ; GENETICA ; GENETICS ; GENETIQUE ; HORMONAS ; HORMONE ; HORMONE RECEPTORS ; HORMONES ; Humans ; INHIBICION ; INHIBITION ; Intracellular Signaling Peptides and Proteins ; Leptin ; LUCIFERASE ; MICE ; Mutation ; Neurons ; Obesity ; Obesity - metabolism ; OXIDOREDUCTASES ; OXIDORREDUCTASAS ; OXYDOREDUCTASE ; PEPTIDE ; PEPTIDES ; PEPTIDOS ; Phosphatases ; PHOSPHOPROTEIN PHOSPHATASE ; PHOSPHORYLATION ; POLYPEPTIDES ; PROMOTERS ; Protein Phosphatase 2 ; Protein Tyrosine Phosphatase, Non-Receptor Type 11 ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 ; Protein Tyrosine Phosphatases - metabolism ; Proteins ; Proteins - metabolism ; RATON ; RECEPTEUR D'HORMONE ; RECEPTORES DE HORMONAS ; Receptors ; Receptors, Cell Surface ; Receptors, Cytokine - genetics ; Receptors, Cytokine - metabolism ; Receptors, Leptin ; RECOMBINANT DNA ; REPORTER GENES ; SH2 Domain-Containing Protein Tyrosine Phosphatases ; Signal Transduction ; SOURIS ; src Homology Domains ; STAT3 Transcription Factor ; TIROSINA ; Trans-Activators - metabolism ; TRANSCRIPCION ; TRANSCRIPTION ; TRANSCRIPTION FACTORS ; Transfection ; TYROSINE</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6061-6066</ispartof><rights>Copyright 1993-1998 National Academy of Sciences</rights><rights>Copyright National Academy of Sciences May 26, 1998</rights><rights>Copyright © 1998, The National Academy of Sciences 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</citedby><cites>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/95/11.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/45331$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/45331$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9600917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creatorcontrib><creatorcontrib>Farruggella, T.J</creatorcontrib><creatorcontrib>Symes, A</creatorcontrib><creatorcontrib>Karow, M.L</creatorcontrib><creatorcontrib>Yancopoulos, G.D</creatorcontrib><creatorcontrib>Stahl, N</creatorcontrib><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</description><subject>ADN RECOMBINADO</subject><subject>ADN RECOMBINE</subject><subject>Animals</subject><subject>Antibodies</subject><subject>BINDING</subject><subject>Biochemistry</subject><subject>Biological Sciences</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>COS Cells</subject><subject>Cytokines</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>ESTERASAS</subject><subject>ESTERASE</subject><subject>ESTERASES</subject><subject>EXPRESION GENICA</subject><subject>EXPRESSION DES GENES</subject><subject>FACTEUR DE TRANSCRIPTION</subject><subject>FACTORES DE TRANSCRIPCION</subject><subject>FOSFORILACION</subject><subject>GENE</subject><subject>GENE EXPRESSION</subject><subject>Gene induction</subject><subject>GENES</subject><subject>GENETIC REGULATION</subject><subject>GENETICA</subject><subject>GENETICS</subject><subject>GENETIQUE</subject><subject>HORMONAS</subject><subject>HORMONE</subject><subject>HORMONE RECEPTORS</subject><subject>HORMONES</subject><subject>Humans</subject><subject>INHIBICION</subject><subject>INHIBITION</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Leptin</subject><subject>LUCIFERASE</subject><subject>MICE</subject><subject>Mutation</subject><subject>Neurons</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>OXIDOREDUCTASES</subject><subject>OXIDORREDUCTASAS</subject><subject>OXYDOREDUCTASE</subject><subject>PEPTIDE</subject><subject>PEPTIDES</subject><subject>PEPTIDOS</subject><subject>Phosphatases</subject><subject>PHOSPHOPROTEIN PHOSPHATASE</subject><subject>PHOSPHORYLATION</subject><subject>POLYPEPTIDES</subject><subject>PROMOTERS</subject><subject>Protein Phosphatase 2</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 11</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 6</subject><subject>Protein Tyrosine Phosphatases - metabolism</subject><subject>Proteins</subject><subject>Proteins - metabolism</subject><subject>RATON</subject><subject>RECEPTEUR D'HORMONE</subject><subject>RECEPTORES DE HORMONAS</subject><subject>Receptors</subject><subject>Receptors, Cell Surface</subject><subject>Receptors, Cytokine - genetics</subject><subject>Receptors, Cytokine - metabolism</subject><subject>Receptors, Leptin</subject><subject>RECOMBINANT DNA</subject><subject>REPORTER GENES</subject><subject>SH2 Domain-Containing Protein Tyrosine Phosphatases</subject><subject>Signal Transduction</subject><subject>SOURIS</subject><subject>src Homology Domains</subject><subject>STAT3 Transcription Factor</subject><subject>TIROSINA</subject><subject>Trans-Activators - metabolism</subject><subject>TRANSCRIPCION</subject><subject>TRANSCRIPTION</subject><subject>TRANSCRIPTION FACTORS</subject><subject>Transfection</subject><subject>TYROSINE</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkcFrFDEUxgdRaq2eBUEZPOhptu9lJpMJeJFSrVDoofYcspk3u1lmkzHJVvvfm2GXpXrQUxK-3_fxXr6ieI2wQBD1-eR0XEi-QFy00OKT4hRBYtU2Ep4WpwBMVF3DmufFixg3ACB5ByfFiWzzFcVpoS_dWjtj3aocaUrWlYHi5F2kcvlQToHuyaVZvb1ilfEuaevm57T2cVrrpDPISusSBW2S9a78adO6vFnmHJMDfXhZPBv0GOnV4Twr7r5cfr-4qq5vvn67-HxdGd5AqrDDBpC4bqkzIEUtBXEAanu27JeG9WKQvcnLGdELol52QgN1PQ68R2JNfVZ82udOu-WWepPnDnpUU7BbHR6U11b9qTi7Vit_r5jgHc_2Dwd78D92FJPa2mhoHLUjv4tKyE4CCPFfENuac8Fm8P1f4Mbvgst_oBhg3eUwzND5HjLBxxhoOA6MoOaG1dywklwhqrnh7Hj7eM8jf6g06x8P-mw8qscANezGMdGvlMl3_yQz8GYPbGIu8kg0vK4fzTFor_Qq2KjublFKAbJm2NW_Ae_1zYY</recordid><startdate>19980526</startdate><enddate>19980526</enddate><creator>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creator><creator>Farruggella, T.J</creator><creator>Symes, A</creator><creator>Karow, M.L</creator><creator>Yancopoulos, G.D</creator><creator>Stahl, N</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><general>The National Academy of Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19980526</creationdate><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><author>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>ADN RECOMBINADO</topic><topic>ADN RECOMBINE</topic><topic>Animals</topic><topic>Antibodies</topic><topic>BINDING</topic><topic>Biochemistry</topic><topic>Biological Sciences</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>COS Cells</topic><topic>Cytokines</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>ESTERASAS</topic><topic>ESTERASE</topic><topic>ESTERASES</topic><topic>EXPRESION GENICA</topic><topic>EXPRESSION DES GENES</topic><topic>FACTEUR DE TRANSCRIPTION</topic><topic>FACTORES DE TRANSCRIPCION</topic><topic>FOSFORILACION</topic><topic>GENE</topic><topic>GENE EXPRESSION</topic><topic>Gene induction</topic><topic>GENES</topic><topic>GENETIC REGULATION</topic><topic>GENETICA</topic><topic>GENETICS</topic><topic>GENETIQUE</topic><topic>HORMONAS</topic><topic>HORMONE</topic><topic>HORMONE RECEPTORS</topic><topic>HORMONES</topic><topic>Humans</topic><topic>INHIBICION</topic><topic>INHIBITION</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Leptin</topic><topic>LUCIFERASE</topic><topic>MICE</topic><topic>Mutation</topic><topic>Neurons</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>OXIDOREDUCTASES</topic><topic>OXIDORREDUCTASAS</topic><topic>OXYDOREDUCTASE</topic><topic>PEPTIDE</topic><topic>PEPTIDES</topic><topic>PEPTIDOS</topic><topic>Phosphatases</topic><topic>PHOSPHOPROTEIN PHOSPHATASE</topic><topic>PHOSPHORYLATION</topic><topic>POLYPEPTIDES</topic><topic>PROMOTERS</topic><topic>Protein Phosphatase 2</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 11</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 6</topic><topic>Protein Tyrosine Phosphatases - metabolism</topic><topic>Proteins</topic><topic>Proteins - metabolism</topic><topic>RATON</topic><topic>RECEPTEUR D'HORMONE</topic><topic>RECEPTORES DE HORMONAS</topic><topic>Receptors</topic><topic>Receptors, Cell Surface</topic><topic>Receptors, Cytokine - genetics</topic><topic>Receptors, Cytokine - metabolism</topic><topic>Receptors, Leptin</topic><topic>RECOMBINANT DNA</topic><topic>REPORTER GENES</topic><topic>SH2 Domain-Containing Protein Tyrosine Phosphatases</topic><topic>Signal Transduction</topic><topic>SOURIS</topic><topic>src Homology Domains</topic><topic>STAT3 Transcription Factor</topic><topic>TIROSINA</topic><topic>Trans-Activators - metabolism</topic><topic>TRANSCRIPCION</topic><topic>TRANSCRIPTION</topic><topic>TRANSCRIPTION FACTORS</topic><topic>Transfection</topic><topic>TYROSINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creatorcontrib><creatorcontrib>Farruggella, T.J</creatorcontrib><creatorcontrib>Symes, A</creatorcontrib><creatorcontrib>Karow, M.L</creatorcontrib><creatorcontrib>Yancopoulos, G.D</creatorcontrib><creatorcontrib>Stahl, N</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</au><au>Farruggella, T.J</au><au>Symes, A</au><au>Karow, M.L</au><au>Yancopoulos, G.D</au><au>Stahl, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1998-05-26</date><risdate>1998</risdate><volume>95</volume><issue>11</issue><spage>6061</spage><epage>6066</epage><pages>6061-6066</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>9600917</pmid><doi>10.1073/pnas.95.11.6061</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6061-6066 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_proquest_miscellaneous_16355727 |
source | JSTOR Archival Journals and Primary Sources Collection; PubMed Central |
subjects | ADN RECOMBINADO ADN RECOMBINE Animals Antibodies BINDING Biochemistry Biological Sciences Carrier Proteins - genetics Carrier Proteins - metabolism COS Cells Cytokines DNA-Binding Proteins - metabolism ESTERASAS ESTERASE ESTERASES EXPRESION GENICA EXPRESSION DES GENES FACTEUR DE TRANSCRIPTION FACTORES DE TRANSCRIPCION FOSFORILACION GENE GENE EXPRESSION Gene induction GENES GENETIC REGULATION GENETICA GENETICS GENETIQUE HORMONAS HORMONE HORMONE RECEPTORS HORMONES Humans INHIBICION INHIBITION Intracellular Signaling Peptides and Proteins Leptin LUCIFERASE MICE Mutation Neurons Obesity Obesity - metabolism OXIDOREDUCTASES OXIDORREDUCTASAS OXYDOREDUCTASE PEPTIDE PEPTIDES PEPTIDOS Phosphatases PHOSPHOPROTEIN PHOSPHATASE PHOSPHORYLATION POLYPEPTIDES PROMOTERS Protein Phosphatase 2 Protein Tyrosine Phosphatase, Non-Receptor Type 11 Protein Tyrosine Phosphatase, Non-Receptor Type 6 Protein Tyrosine Phosphatases - metabolism Proteins Proteins - metabolism RATON RECEPTEUR D'HORMONE RECEPTORES DE HORMONAS Receptors Receptors, Cell Surface Receptors, Cytokine - genetics Receptors, Cytokine - metabolism Receptors, Leptin RECOMBINANT DNA REPORTER GENES SH2 Domain-Containing Protein Tyrosine Phosphatases Signal Transduction SOURIS src Homology Domains STAT3 Transcription Factor TIROSINA Trans-Activators - metabolism TRANSCRIPCION TRANSCRIPTION TRANSCRIPTION FACTORS Transfection TYROSINE |
title | Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A23%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20leptin%20response%20by%20preventing%20SH2-containing%20phosphatase%202%20interaction%20with%20Ob%20receptor&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Carpenter,%20L.R.%20(Regeneron%20Pharmaceuticals,%20Inc.,%20Tarrytown,%20NY.)&rft.date=1998-05-26&rft.volume=95&rft.issue=11&rft.spage=6061&rft.epage=6066&rft.pages=6061-6066&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.95.11.6061&rft_dat=%3Cjstor_proqu%3E45331%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201380771&rft_id=info:pmid/9600917&rft_jstor_id=45331&rfr_iscdi=true |